missing translation for 'onlineSavingsMsg'
Läs mer
Läs mer
Lifirafenib, MedChemExpress
Beskrivning
Lifirafenib (BGB-283) is a novel and potent Raf Kinase and EGFR inhibitor with IC50 values of 23 and 29 nM for recombinant BRafV600E and EGFR, respectively.
Specifikationer
Specifikationer
| Kemiskt namn eller material | Lifirafenib |
| CAS | 1446090-79-4 |
| Färg | Off-White |
| Anteckningar om renhetsgrad | Research |
| Molekylformel | C25H17F3N4O3 |
| Kvantitet | 100 mg |
| Synonym | BGB-283 |
| Löslighetsinformation | DMSO : ≥ 100 mg/mL (209.02 mM) |
| LEDER | O=C1NC2=NC=CC(OC3=CC=C(O[C@@]4([H])[C@]5([H])[C@@H]4C6=NC7=CC=C(C(F)(F)F)C=C7N6)C5=C3)=C2CC1 |
| Molekylvikt (g/mol) | 478.42 |
| Show More |
Research purposes only
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?